Position in ZTS
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$0
-$531,472 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Erste Asset Management GmbH holds $19,400,632 across 6 Drug Manufacturers - Specialty & Generic names. ZTS ranks #6 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
28,831 | $15,621,500 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
19,700 | $3,320,238 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
|
40,000 | $400,000 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
3,674 | $58,894 | |
| 5 | RDY |
Dr Reddys Laboratories Ltd
|
0 | $0 | |
| 6 | ZTS |
Zoetis Inc.
This page
|
0 | $0 |
All Filings in ZTS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $0 | 0 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $531,472 | 4,496 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $576,381 | 4,581 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $10,907,278 | 74,544 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $21,642,117 | 138,776 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $17,115,532 | 103,951 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $23,199,113 | 142,387 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $19,464,341 | 99,623 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,142,204 | 29,662 | Shares | Sole | 2024-11-26 | |
| 2024-03-31 | $4,907,259 | 29,001 | Shares | Sole | 2024-11-26 | |
| 2023-12-31 | $5,676,755 | 28,762 | Shares | Sole | 2024-11-26 | |
| 2023-09-30 | $1,394,275 | 8,014 | Shares | Sole | 2024-11-26 | |
| 2023-06-30 | $1,165,517 | 6,768 | Shares | Sole | 2024-11-26 | |
| 2023-03-31 | $739,992 | 4,446 | Shares | Sole | 2024-11-26 | |
| 2022-12-31 | $1,044,461 | 7,127 | Shares | Sole | 2024-11-26 | |
| 2022-09-30 | $415,212 | 2,800 | Shares | Sole | 2024-11-26 | |
| 2022-06-30 | $481,292 | 2,800 | Shares | Sole | 2024-11-26 | |
| 2022-03-31 | $932,200 | 4,943 | Shares | Sole | 2024-11-25 | |
| 2021-12-31 | $1,061,042 | 4,348 | Shares | Sole | 2024-11-25 | |
| 2021-09-30 | $543,592 | 2,800 | Shares | Sole | 2024-11-25 | |
| 2021-06-30 | $521,808 | 2,800 | Shares | Sole | 2024-11-25 | |
| 2021-03-31 | $89,133 | 566 | Shares | Sole | 2024-11-25 | |
| 2020-12-31 | $9,030,673 | 54,566 | Shares | Sole | 2024-11-25 | |
| 2020-09-30 | $11,351,658 | 68,644 | Shares | Sole | 2024-11-25 | |
| 2020-06-30 | $9,277,608 | 67,700 | Shares | Sole | 2024-11-22 | |
| 2020-03-31 | $5,672,658 | 48,200 | Shares | Sole | 2024-11-22 | |
| No filing history on record for this holder in this stock. | ||||||